New Leadership in Technology Transfer at UT
January 20, 2025 - 08:06
The University of Texas has announced the appointment of Andrew Maas as the new assistant vice president for the Discovery to Impact team, effective immediately. This strategic move aims to enhance the university's technology transfer initiatives and bolster student entrepreneurship.
The Discovery to Impact team is dedicated to collaborating with inventors, startups, and established businesses to transform innovative ideas into viable products and services. Under Maas's leadership, the team will focus on commercializing research conducted at the university, ensuring that groundbreaking discoveries benefit society and drive economic growth.
Maas brings a wealth of experience in technology commercialization and entrepreneurship, having worked in various roles that bridge academia and industry. His vision includes fostering an entrepreneurial ecosystem that empowers students and researchers to turn their ideas into reality. This appointment signals a renewed commitment by the university to support innovation and create pathways for students to engage in entrepreneurial ventures.
MORE NEWS
March 2, 2026 - 07:46
Canon: "New Technology" Compact Model is ComingPhotography enthusiasts and industry watchers are abuzz as Canon has released tantalizing hints about a new compact camera model currently in development. While full specifications and an official...
March 1, 2026 - 18:53
Digital Frontiers Reshape Montana's LandscapeThe spirit of innovation that once rode the rails into Montana is finding new expression in the digital age. Across the state, from sprawling ranches to remote mountain towns, modern technology is...
March 1, 2026 - 04:37
Silicon Valley Rallies Behind Anthropic in A.I. Clash With TrumpA significant rift appears to be widening between the federal government and the American technology sector, as industry leaders and workers rally behind artificial intelligence startup Anthropic....
February 28, 2026 - 04:58
Rare Disease Day: Revolutionising clinical trial enrolment and retention with technologyOn Rare Disease Day, the focus sharpens on the unique challenges of developing treatments for conditions affecting small, often geographically dispersed patient populations. A key industry expert...